10 x 99% purity CJC 1295 with DAC 2mg

Description

Classification 

10 x 99% Purity CJC 1295 with DAC 2mg is classified as an experimental long-acting GHRH analog. The DAC component is intended to extend the peptide’s activity by increasing its interaction with albumin in circulation, allowing CJC-1295 to remain biologically active for considerably longer than naturally occurring GHRH.

CJC-1295 has been studied in healthy adults for its effects on the GH–IGF-1 axis. In a randomized, placebo-controlled human study, CJC-1295 produced sustained, dose-dependent increases in GH and IGF-1.

Product specifications include:

• Compound: CJC-1295 with DAC
• Stated purity: 99%
• Quantity: 10 units
• Amount per unit: 2mg
• Total stated quantity: 20mg
• Category: Experimental peptide research compound
• Primary research focus: GHRH, GH, and IGF-1 signaling

What Is 10 x 99% Purity CJC 1295 With DAC 2mg?

10 x 99% Purity CJC 1295 with DAC 2mg is a bulk research supply of CJC-1295 containing the Drug Affinity Complex. The product is intended to provide a longer-acting research form of a GHRH analog for laboratory investigation of growth hormone signaling.

In human research, a single administration of CJC-1295 resulted in dose-dependent increases in plasma GH for six days or more and increased IGF-1 concentrations for approximately 9–11 days. The estimated half-life was approximately 5.8–8.1 days.

These findings demonstrate pharmacological activity but do not establish that a particular 2mg research product is safe, sterile, or appropriate for personal administration.

Dosage

There is no FDA-approved human dosage for CJC-1295 with DAC. The 2mg amount represents the stated quantity supplied per unit and should not be interpreted as a recommended clinical dose.

The published human study used experimental weight-based doses rather than a fixed 2mg regimen. Its findings cannot simply be converted into instructions for using a separately manufactured research product.

Important considerations include:

• 2mg is the stated quantity per unit.
• It is not an approved human dose.
• Research concentrations depend on the study design.
• Clinical-trial doses should not be repurposed as self-treatment instructions.
• Qualified researchers should follow their approved protocols.

How Does 10 x 99% Purity CJC 1295 With DAC 2mg Work?

CJC-1295 with DAC is designed to mimic the activity of growth hormone-releasing hormone (GHRH). GHRH normally stimulates the pituitary gland to release growth hormone.

Increasing GHRH-related signaling can subsequently increase GH secretion and influence production of IGF-1. This makes CJC-1295 useful for experimental research involving endocrine signaling, hormonal physiology, and the GH–IGF-1 pathway.

A controlled human study found that CJC-1295 produced dose-dependent increases in GH and IGF-1 and maintained IGF-1 levels above baseline for an extended period following repeated administration.

Benefits 

The primary research interest in CJC-1295 with DAC involves prolonged stimulation of the GH–IGF-1 axis. Its long-acting characteristics make it useful for investigating sustained hormonal responses.

Research areas include:

• Growth hormone signaling
• IGF-1 regulation
• GHRH receptor activity
• Endocrine physiology
• Hormonal feedback mechanisms
• Long-acting peptide pharmacology
• Protein metabolism research
• Body-composition research

The human study demonstrated sustained GH and IGF-1 elevation, but this should not be interpreted as proof that CJC-1295 with DAC is an approved treatment for muscle growth, fat loss, anti-aging, or athletic performance.

When Should You Take 10 x 99% Purity CJC 1295 With DAC 2mg?

Do not use this research product according to an online dosing schedule. CJC-1295 with DAC does not have an FDA-approved administration schedule for self-directed use.

Clinical research has evaluated different dosing schedules under controlled conditions. Those research protocols should not be applied directly to a separate 2mg research product.

For legitimate laboratory research, administration timing and experimental exposure should be established according to the approved protocol, research model, and institutional requirements.

When Should You Not Take 10 x 99% Purity CJC 1295 With DAC 2mg?

CJC-1295 with DAC should not be self-administered or treated as an alternative to approved endocrine therapy. FDA lists CJC-1295 among substances for which available clinical safety information is limited and identifies potential risks involving immunogenicity and peptide-related impurities.

Do not use this research material as:

• A prescription growth hormone treatment
• A muscle-building medication
• An anti-aging treatment
• A weight-loss medication
• An athletic performance drug
• A replacement for endocrine care
• A self-directed injectable therapy

People with suspected growth hormone deficiency or other endocrine disorders should receive evaluation and treatment from a qualified healthcare professional.

What Is the Mechanism of 10 x 99% Purity CJC 1295 With DAC 2mg?

CJC-1295 with DAC acts through the GHRH pathway. The peptide is designed to stimulate GHRH receptors on pituitary somatotroph cells, increasing GH secretion.

The DAC modification contributes to prolonged activity by facilitating interaction with circulating albumin. FDA’s technical review notes that this albumin interaction contributes to the extended pharmacokinetic profile of CJC-1295 DAC.

The increased GH signal can subsequently influence IGF-1 production through the liver and other tissues. Human research has confirmed prolonged increases in both GH and IGF-1 after CJC-1295 administration.

Uses: Laboratory and Experimental Applications of CJC 1295 With DAC

Qualified researchers may investigate CJC-1295 with DAC in controlled studies involving:

• GHRH receptor signaling
• Growth hormone secretion
• IGF-1 production
• Endocrine physiology
• Hormonal feedback mechanisms
• Long-acting peptide pharmacology
• Metabolic research
• GH–IGF-1 axis studies

These are research applications rather than FDA-approved medical indications.

Warnings and Precautions for 10 x 99% Purity CJC 1295 With DAC 2mg

CJC-1295 requires careful consideration of product identity and quality. FDA has identified concerns involving immunogenicity, peptide-related impurities, and API characterization. FDA has also identified serious adverse events associated with CJC-1295, including increased heart rate and systemic vasodilatory reactions.

FDA’s technical review also identified nonclinical safety signals involving repeated administration of CJC-1295 DAC, including injection-site hemorrhage, inflammation, and necrosis in animal studies.

Important precautions include:

• Verify the exact CJC-1295 DAC identity.
• Review batch-specific analytical documentation.
• Confirm stated purity and formulation.
• Review available impurity and aggregate information.
• Do not infer human safety from animal research.
• Do not convert research quantities into personal doses.
• Follow appropriate laboratory handling procedures.
• Keep research materials away from unauthorized users.

A stated 99% purity does not establish pharmaceutical equivalence, sterility, clinical safety, or FDA approval.

Side Effects of 10 x 99% Purity CJC 1295 With DAC 2mg

The human safety database for CJC-1295 is limited. The early controlled human study reported no serious adverse reactions, but it involved relatively small groups of healthy adults and was not designed to establish long-term safety.

FDA’s review subsequently identified serious adverse events associated with CJC-1295, including increased heart rate and systemic vasodilatory reaction, while emphasizing that available clinical data remain limited.

FDA has also noted nonclinical concerns associated with CJC-1295 DAC, including local injection-site safety signals and unresolved long-term safety questions.

Therefore, a comprehensive human side-effect profile has not been established.

Storage for 10 x 99% Purity CJC 1295 With DAC 2mg

Store 10 x 99% Purity CJC 1295 with DAC 2mg according to the manufacturer’s current product documentation. Peptide stability depends on formulation, packaging, temperature, moisture, and handling conditions.

General storage practices include:

• Keep units in their original labeled containers.
• Follow manufacturer-specific temperature requirements.
• Protect the material from contamination.
• Minimize unnecessary environmental exposure.
• Monitor expiration or retest information.
• Maintain appropriate laboratory storage records.
• Restrict access to authorized personnel.

Manufacturer-specific instructions should take priority over generalized recommendations.

Where to Buy 10 x 99% Purity CJC 1295 With DAC 2mg?

To get 10 x 99% purity CJC 1295 with DAC 2mg online, go to USA Elite Steroid, today to get the best deal on this medicine .

Frequently Asked Questions

1. What is 10 x 99% Purity CJC 1295 With DAC 2mg?

It is a bulk research product containing ten individual 2mg units of CJC-1295 with Drug Affinity Complex and a stated purity of 99%. The stated total quantity is 20mg.

2. What is CJC-1295 with DAC researched for?

CJC-1295 with DAC has been investigated primarily for its effects on GHRH signaling, growth hormone secretion, IGF-1 production, and prolonged endocrine activity.

3. Is CJC-1295 with DAC FDA approved?

No. CJC-1295 is not an FDA-approved human medication. FDA has identified limited clinical safety information and potential concerns involving immunogenicity, peptide-related impurities, and API characterization.

4. Does CJC-1295 with DAC have an established human dosage?

No FDA-approved human dosage has been established. A controlled human study evaluated experimental weight-based doses, but those research parameters should not be used as instructions for administering a separate 2mg product.

5. How much CJC-1295 with DAC is included in this product?

The stated package contains 10 units at 2mg each, providing a total stated quantity of 20mg.